Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-006819
Filing Date
2015-08-10
Accepted
2015-08-10 16:00:48
Documents
15
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pbyi-10q_20150630.htm 10-Q 1347797
2 EX-10.1 pbyi-ex101_82.htm EX-10.1 13036
3 EX-10.2 pbyi-ex102_132.htm EX-10.2 186977
4 EX-31.1 pbyi-ex311_8.htm EX-31.1 12428
5 EX-31.2 pbyi-ex312_6.htm EX-31.2 12420
6 EX-32.1 pbyi-ex321_7.htm EX-32.1 9173
7 EX-32.2 pbyi-ex322_9.htm EX-32.2 9188
8 GRAPHIC g201508072227076241179.jpg GRAPHIC 3891
9 GRAPHIC g201508072227074211178.jpg GRAPHIC 56713
  Complete submission text file 0001564590-15-006819.txt   5515466

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT pbyi-20150630.xml EX-101.INS 1206536
11 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20150630.xsd EX-101.SCH 34818
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20150630_cal.xml EX-101.CAL 33188
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20150630_def.xml EX-101.DEF 96818
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20150630_lab.xml EX-101.LAB 309374
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20150630_pre.xml EX-101.PRE 227881
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 151040649
SIC: 2834 Pharmaceutical Preparations